Axsome Therapeutics Inc. (AXSM)
Market is closed
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
- 1 - 5
- Next >>
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 1,690,221 | $197,130,475 | +22% | 8.03% |
| 2. | Partner Fund Management Christopher Medlock James | 556,545 | $64,909,843 | +20% | 4.71% |
| 3. | D E Shaw D. E. Shaw | 547,665 | $63,874,169 | +2592% | 0.06% |
| 4. | GLG Partners Noam Gottesman | 513,221 | $59,856,965 | +215% | 0.15% |
| 5. | OrbiMed Advisors Samuel Isaly | 386,700 | $45,100,821 | 1.08% |
Billionaire Hedge Funds
